Efficacy and Safety of Tribendimidine Against Clonorchis sinensis | Zendy

MenBao Qian | Zendy; Peiling Yap | Zendy; Yichao Yang | Zendy; Liang Hai | Zendy; Zhi-Hua Jiang | Zendy; Wěi Li | Zendy; Tan YuGuang | Zendy; Hui Zhou | Zendy; Jürg Utzinger | Zendy; Xiaog Zhou | Zendy; Jennifer Keiser | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Tribendimidine Against Clonorchis sinensis

Author(s) -

MenBao Qian,

Peiling Yap,

Yichao Yang,

Liang Hai,

Zhi-Hua Jiang,

Wěi Li,

Tan YuGuang,

Hui Zhou,

Jürg Utzinger,

Xiaog Zhou,

Jennifer Keiser

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis1011

Subject(s) - clonorchis sinensis , praziquantel , clonorchiasis , medicine , adverse effect , gastroenterology , pharmacology , schistosomiasis , immunology , helminths

Clonorchiasis is of considerable public health importance, particularly in the People's Republic of China (PR China), where most of the 15 million individuals infected with Clonorchis sinensis are currently concentrated. Praziquantel is the drug of choice, but tribendimidine might be an alternative.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research